Poland: New medical device obligations take effect 1 July 2023

In brief

1 July 2023 saw the last provisions of the Act of 7 April 2022 on Medical Devices ("MD Act") enter into force. The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products ("Office") launched two new online platforms: a list of distributors and a list of users of medical devices. Moreover, since 1 July also an obligation of manufacturers, authorized representatives and importers of custom-made devices to register their activities in Poland before placing such device on the market also came in force.


Key takeaways

Polish regulator of the medical devices market has launched new online registration systems intended for:

  • distributors of medical devices, systems or procedure packs, 
  • professional users bringing medical devices, systems and procedure packs to Poland,
  • manufacturers, authorized representatives and importers of custom-made devices.

Although the systems became operational on 1 July 2023, some of them have not yet become mandatory for the users, due to certain transition periods provided for in the MD Act. During the transition periods, the companies may follow the previously applicable registration procedures which remain in force on a temporary basis.

Non-compliance with the new obligations can attract a financial penalty of up to PLN 200,000 (EUR 44,500).

List of distributors and users of medical devices

The following two platforms have been launched on the website of the Office:

  •  a list of distributors of medical devices, systems or procedure packs based in Poland, as referred to in Article 21 of the MD Act (link), where entities distributing medical devices will be obliged to create an account and submit information about the first introduction of devices onto the Polish market
  • a list of users of medical devices, i.e., a system designed to collect information on devices, systems and procedure packs verified brought into the territory of Poland by entities or persons performing medical activities and other entities that use medical devices for business or professional activities as referred to in Article 22 of the MD Act (link)

Registration takes place online. An access code (login) is generated once an account has been created and an application form is sent to the e-mail address provided during registration. The application form needs to be printed and signed by hand or electronically by a person or persons authorized to represent the entity. 

The application can be submitted: (i) in person at the Office, or (ii) electronically via an electronic public services (ePUAP) using the trusted profile of the person representing the entity, or (iii) electronically, using the qualified electronic signature of the person representing the entity, to the e-mail address: urpl@urpl.gov.pl, or (iv) by ordinary mail.

Once the data has been verified, the account will be activated. Information on activation will be sent to the e-mail address provided at registration along with the password.

With respect to medical devices, systems or procedure packs made available on the territory of Poland for the first time (and not notified before 1 July), the distributor will provide the following data:

  • Basic UDI-DI code of the medical device, system or procedure pack,
  • name and address of the manufacturer,
  • type and trade name of the medical device, system or procedure pack

- within seven days from the date of introducing the medical device, system or procedure pack into the territory of Poland.

Custom-made devices – registration of activities

As of 1 July 2023: 

  •  a manufacturer of a custom-made device
  • an authorized representative of a manufacturer of a custom-made device who is not domiciled or established in a Member State
  • an importer of a custom-made product 

- are obliged to submit an application for registration of their activities to the Office before placing a device on the market.

The obligation applies to entities that are domiciled or seated on the territory of Poland.

The application for registration should be submitted by a person authorized to represent a given entity or by a proxy in one of the following ways:

  • by means of the dedicated online platform maintained by the Office
  • in person at the Office, showing respective proof of identity (ID, passport)
  • in electronic form through the ePUAP platform using the trusted profile of the person representing the entity
  • in electronic form using the qualified electronic signature of the person representing the entity to the e-mail address: urpl@urpl.gov.pl, or signed using a personal signature (i.e., advanced electronic signature verified by the personal signature’s certificate)
  • signed by the person representing the entity and certified by a notary public (in the form of a letter

An application submitted by an authorized representative must be accompanied by: (i) an extract from the relevant business register that is no more than three months old, legalized by the respective consul of Poland or apostilled, (ii) authorization of the person representing the entity and the rules of representation executed before a notary public or other publicly trusted entity no earlier than three months before the submission and legalized by the respective consul of Poland or apostilled, (iii) the appointment referred to in the Article 11(1) of the MDR or IVMDR. All the above documents need to be translated by a sworn translator.

If the dedicated system operated by the Office is used, an access code (login) will be generated once an account has been created and an application form will be sent to the e-mail address indicated during registration. The form must be printed out, signed and submitted to the Office as specified above. 

After data verification, the account will be activated. Information on the activation will be sent to the e-mail address provided at registration, along with the password.

Transition period

The MD Act assumes a transition period lasting until 30 June 2024, during which the distributors and manufacturers, authorized representatives and importers of custom-made devices have a choice – notification can be filed under the previously applicable rules or using the new online platform.

After 30 June 2024, it will only be possible to discharge the registration obligation by using the new registration procedures referred to above. The transition period means that the devices notified to the Office on the basis of previously applicable regulations are not subject to registration in the new system. 

Sanctions

Non-compliance with the new obligations can attract a financial penalty of up to PLN 200,000 (EUR 44,500).


Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.